US Drug Recall Register
Class III · Low risk Terminated Initiated Oct 12, 2021 (5 years ago)

Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate…

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Failed Moisture Limits

What was recalled

Loratadine-D Extended-Release Tablets (Loratadine and Pseudoephedrine Sulfate, Extended-Release Tablets, USP 10mg/240mg) , 10-count blister packs, Distributed By Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-5833-15

Recalling firm
Sun Pharmaceutical Industries INC
NDC code
0904-5833-15
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0068-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Ephedrine recalls

See all